Bristol-Myers Squibb Company v. Azurity Pharmaceuticals, Inc

Court

District Court, D. Delaware (D. Del.)
Official Court Website →

Assigned judge

Unassigned Judge · 2,770 cases in index

Docket number

1:25-cv-01558

Cause

35:271 Patent Infringement
35 U.S.C. § 271 — Patent infringement

Nature of suit

835 Patent - Abbreviated New Drug Application(ANDA)
Hatch-Waxman patent disputes over a generic-drug (ANDA) application.

Jurisdiction

Federal Question

Jury demand

None

Date filed

12/23/2025

1,113 Patent - ANDA cases in this court are indexed here.

Parties

• plaintiff · Bristol-Myers Squibb Pharmaceuticals & Biotechnology · 9426 cases
• defendant · Azurity Pharmaceuticals, Inc · 26 cases

Part of a Larger Litigation Pattern

This is one of 27 Patent - ANDA cases in our index naming Azurity Pharmaceuticals, Inc — a possible mass-tort or coordinated-litigation cluster.

• Azurity Pharmaceuticals, Inc v. Annora Pharma Private Limited
  District Court, D. DelawareFiled 09/12/2025
• Exelixis, Inc v. Azurity Pharmaceuticals, Inc
  District Court, D. DelawareFiled 04/18/2025
• Heron Therapeutics, Inc v. Azurity Pharmaceuticals, Inc
  District Court, D. DelawareFiled 12/12/2024
• Merck Sharp & Dohme LLC v. Azurity Pharmaceuticals, Inc
  District Court, D. DelawareFiled 05/03/2024
• Azurity Pharmaceuticals, Inc v. Aurobindo Pharma Ltd
  District Court, D. New JerseyFiled 12/21/2023
• Azurity Pharmaceuticals, Inc v. Teva Pharmaceuticals, Inc
  District Court, D. DelawareFiled 09/29/2023

About Patent - ANDA Lawsuits

ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.

Frequently Asked Questions

What is Bristol-Myers Squibb Company v. Azurity Pharmaceuticals, Inc?

Bristol-Myers Squibb Company v. Azurity Pharmaceuticals, Inc is a federal patent - anda lawsuit filed on 12/23/2025 in the District Court, D. Delaware. The case is currently open in the federal court system. ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.

What type of case is this?

It is classified as “Patent - ANDA” under the federal nature-of-suit system. ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.

What court is the case in?

The case is in the District Court, D. Delaware, docket number 1:25-cv-01558.

When was the case filed?

Bristol-Myers Squibb Company v. Azurity Pharmaceuticals, Inc was filed on 12/23/2025. The case is currently open.

What law is the case brought under?

The docket lists the cause as 35 U.S.C. § 271 — Patent infringement.